Status:
UNKNOWN
KurCoSmart Effects on People With Type 2 DM
Lead Sponsor:
Universitas Sebelas Maret
Conditions:
Diabetes Mellitus, Type 2
Insulin Resistance
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The investigators aim to evaluate the effect of curcumin and virgin coconut oil extract supplementation on people with type 2 DM, including blood glucose, HbA1c levels, inflammation, body weight and i...
Detailed Description
The investigators give Kurcosmart supplementation aside from diabetes standard treatment to evaluate its benefits on people with type 2 DM, considering its effect on controlling fasting and prandial b...
Eligibility Criteria
Inclusion
- Confirmed Type 2 DM
- Signing consent form
Exclusion
- Pregnant or breastfeeding
- Multiple organ failure
- History of hypersensitivity reaction to curcumin and virgin coconut oil
- Cancer, renal insufficiency, hematological disease, acute heart failure, chronic liver disease
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05407467
Start Date
June 1 2022
End Date
September 1 2022
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNS Hospital
Sukoharjo, Central Java, Indonesia, 57161